KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $23.6 million.

  • Evolent Health's Depreciation & Amortization (CF) fell 2049.09% to $23.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.1 million, marking a year-over-year decrease of 1564.43%. This contributed to the annual value of $118.4 million for FY2024, which is 408.78% down from last year.
  • Evolent Health's Depreciation & Amortization (CF) amounted to $23.6 million in Q3 2025, which was down 2049.09% from $23.1 million recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Depreciation & Amortization (CF) peaked at $32.4 million during Q3 2023, and registered a low of $14.9 million during Q3 2021.
  • For the 5-year period, Evolent Health's Depreciation & Amortization (CF) averaged around $23.1 million, with its median value being $23.6 million (2025).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 11263.9% in 2023, then tumbled by 2252.76% in 2025.
  • Quarter analysis of 5 years shows Evolent Health's Depreciation & Amortization (CF) stood at $14.9 million in 2021, then soared by 32.62% to $19.8 million in 2022, then surged by 49.65% to $29.6 million in 2023, then fell by 1.03% to $29.3 million in 2024, then decreased by 19.39% to $23.6 million in 2025.
  • Its last three reported values are $23.6 million in Q3 2025, $23.1 million for Q2 2025, and $24.1 million during Q1 2025.